Amyloidosis: Risk Factors, Treatment Options & Clinical Aspects | Agenda Bookshop Skip to content
Please note that books with a 10-20 working days delivery time may not arrive before Christmas.
Please note that books with a 10-20 working days delivery time may not arrive before Christmas.
Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=Raquel Watts
Category1=Non-Fiction
Category=MBGR
Category=MFGM
COP=United States
Delivery_Delivery within 10-20 working days
Language_English
PA=Available
Price_€100 and above
PS=Active
softlaunch

Amyloidosis: Risk Factors, Treatment Options & Clinical Aspects

English

Amyloidosis is a result of the abnormal deposition of amyloid resulting in the disruption of organ and tissue function, which can be localised or systemic, with the kidney being most frequently affected. This book discusses the risk factors, treatment options and clinical aspects of amyloidosis. Chapter One explores amyloid cardiomyopathy. Chapter Two summarises current investigations utilising RNAi and immunotherapy to target the amyloid protein itself. Chapter Three reviews genetic counseling as an important component of the treatment algorithm for amyloidosis. Chapter Four discusses tissue examination in a diagnostic procedure. Chapter Five reviews protein studies in light-chain amyloidosis. See more
Current price €122.54
Original price €128.99
Save 5%
Age Group_Uncategorizedautomatic-updateB01=Raquel WattsCategory1=Non-FictionCategory=MBGRCategory=MFGMCOP=United StatesDelivery_Delivery within 10-20 working daysLanguage_EnglishPA=AvailablePrice_€100 and abovePS=Activesoftlaunch
Delivery/Collection within 10-20 working days
Product Details
  • Weight: 226g
  • Dimensions: 155 x 230mm
  • Publication Date: 01 Dec 2016
  • Publisher: Nova Science Publishers Inc
  • Publication City/Country: United States
  • Language: English
  • ISBN13: 9781634858847

Customer Reviews

No reviews yet
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept